Check Point Software Technologies: Subscription Growth Improved And Valuation Is Now Cheap (Rating Upgrade)

Check Point (CHKP) was upgraded to Buy as subscription growth re-accelerates to 12% y/y, reversing earlier recurring-revenue softness. While product revenue fell 14% y/y, the firm cites easier H2 comps and go-to-market restructuring for a second-half recovery. New AI Network Firewall and Verity are expected to sustain subscription momentum and support future recurring revenue growth.

Analysis

The market mechanism here is not near-term growth, it is durability. If recurring mix keeps improving, CHKP can trade less like a tired value trap and more like a cash-generative security compounder, which matters because software multiples are driven by confidence in next-year ARR more than this quarter’s product line. The AI-branded launches are likely more important as sales-enablement and upsell hooks than as immediate revenue contributors; the real prize is higher renewal rates and lower churn, not headline AI monetization.

The risk is that this is a transition story, not an inflection. Product weakness alongside subscription strength can reflect mix shift, pricing, or deferred demand rather than broad end-market share gains, so the upgrade thesis fails if billings/RPO do not re-accelerate over the next 1-2 quarters. Competitively, PANW, FTNT, ZS, and CRWD are the relevant read-throughs: if CHKP’s recurring growth is real, it suggests budget is still there for security spend, but buyers are favoring sticky subscriptions over box revenue, which is negative for vendors still reliant on hardware or one-off deal cycles.

Contrarian view: this may be too small a fundamental change to justify a big rerating unless management proves it in backlog and net retention. The immediate price reaction can be better than the 6-18 month setup if the market is shorting a slow-growth name into an upgrade, but without sustained billings improvement the move should fade. I would treat this as a confirmation trade, not a momentum chase: the upside is a multiple re-rating, the downside is reversion back to a low-expectation cash-flow compounder.

Key Decisions for Investors

• Small tactical long CHKP only on pullbacks, sized for a 1-2 quarter confirmation window; target a modest multiple rerating if the next print shows subscription growth holding and billings/RPO inflecting, with thesis invalidation if product revenue stays weak and guide does not improve.
• Prefer CHKP over more hardware-exposed security vendors on a relative basis; pair long CHKP / short FTNT if you want to express the mix-shift thesis, since the trade is about recurring revenue quality rather than absolute industry growth.
• Do not chase CHKP calls on the upgrade alone; the catalyst path is measured in quarters, not days, and the absence of independently visible monetization from AI products limits upside from narrative alone.
• Set a watch item on next-quarter billings, remaining performance obligations, and net retention; if those do not accelerate, exit the long and assume the subscription improvement was largely timing or pricing-driven.